Form 4: GE HealthCare Technologies Inc. Executive Reports Stock Transactions
SEC Form 4 Filing
George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reports acquisition and disposal of company stock and stock options.
Summary
- On March 1, 2025, George A. Newcomb disposed of 342 shares of GE HealthCare common stock at $87.35 per share to satisfy tax withholding obligations related to vesting restricted stock units.
- On March 3, 2025, Newcomb acquired 1,156 shares of GE HealthCare common stock through restricted stock units.
- Newcomb was also granted an employee stock option to purchase 3,307 shares of GE HealthCare common stock at an exercise price of $86.45 on March 3, 2025.
- Following these transactions, Newcomb directly owns 7,705 shares and indirectly owns 12 shares through a family member.
- The stock options and restricted stock units vest in three tranches on September 3, 2026, September 3, 2027, and September 3, 2028.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and insider trading reporting, suggesting a neutral to slightly positive sentiment due to alignment of executive interests with company performance.
Positives
- The grant of restricted stock units and stock options to the Chief Accounting Officer aligns his interests with the long-term performance of the company.
- The vesting schedule of the stock options and restricted stock units encourages long-term commitment from the executive.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule of the stock options and restricted stock units suggests a long-term incentive structure for the executive.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates standard executive compensation practices.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align executive interests with shareholder value.
- Vesting schedules are common to encourage long-term commitment and performance.
- The specific terms of the stock options and restricted stock units (e.g., vesting schedule, exercise price) are typical for executive compensation packages in publicly traded companies.
Stakeholder Impact
- Shareholders may view the stock transactions as a sign of management's confidence in the company's future prospects.
- Employees may see the executive compensation package as a reflection of the company's commitment to rewarding performance.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Disposal of shares for tax withholding. |
| 03/03/2025 | Acquisition of shares via restricted stock units and grant of employee stock options. |
| 03/05/2025 | Date of Form 4 signature. |
| 09/03/2026 | First vesting date (33%) for restricted stock units and stock options. |
| 09/03/2027 | Second vesting date (33%) for restricted stock units and stock options. |
| 09/03/2028 | Final vesting date (34%) for restricted stock units and stock options. |
| 03/03/2035 | Expiration date for employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.